Vicore Pharma Holding AB (OSTO:VICO) Other Stockholders Equity : kr0.0 Mil (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Vicore Pharma Holding AB Other Stockholders Equity?

Vicore Pharma Holding AB's Other Stockholders Equity for the quarter that ended in Dec. 2024 was kr0.0 Mil.

Vicore Pharma Holding AB's quarterly Other Stockholders Equity declined from Jun. 2024 (kr435.0 Mil) to Sep. 2024 (kr377.7 Mil) and declined from Sep. 2024 (kr377.7 Mil) to Dec. 2024 (kr0.0 Mil).

Vicore Pharma Holding AB's annual Other Stockholders Equity declined from Dec. 2022 (kr0.0 Mil) to Dec. 2023 (kr-0.0 Mil) but then increased from Dec. 2023 (kr-0.0 Mil) to Dec. 2024 (kr0.0 Mil).

Vicore Pharma Holding AB Other Stockholders Equity Historical Data

The historical data trend for Vicore Pharma Holding AB's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vicore Pharma Holding AB Other Stockholders Equity Chart

Vicore Pharma Holding AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Stockholders Equity

Get a 7-Day Free Trial

Vicore Pharma Holding AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Stockholders Equity	Get a 7-Day Free Trial															-	488.83	434.98	377.74	-

Vicore Pharma Holding AB Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Vicore Pharma Holding AB Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Vicore Pharma Holding AB's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Vicore Pharma Holding AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vicore Pharma Holding AB (OSTO:VICO) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

6Y4:Germany

Address

Kornhamnstorg 53, Stockholm, SWE, 111 27

Website

https://www.vicorepharma.com

Vicore Pharma Holding AB is as a clinical-stage pharmaceutical company focused on severe lung diseases. The company is establishing a portfolio in respiratory diseases, including idiopathic pulmonary fibrosis (IPF). Its C21 is a small molecule angiotensin II type 2 receptor agonist (ATRAG) currently in phase 2a development for IPF. The company also has an investigational medical device in clinical development namely, Almee which is a digital therapeutic leveraging cognitive behavioral therapy created to address the psychological impact of living with pulmonary fibrosis.

Vicore Pharma Holding AB Headlines

No Headlines